ENvue Medical (FEED) Shares Outstanding (Diluted Average) (2014 - 2026)
ENvue Medical (FEED) reported Shares Outstanding (Diluted Average) of $3.3 million for Q1 2026, up 5152.81% year-over-year from $62615.0 in Q1 2025, and up 423.29% on a QoQ basis from $628534.0 in Q4 2025.
ENvue Medical (FEED) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $3.3 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 5152.81% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 5152.81% YoY) and the FY2025 annual result came in at $628534.0, up 2229.2% from the prior year.
- Shares Outstanding (Diluted Average) climbed to $3.3 million in Q1 2026 per FEED's latest filing, from $628534.0 in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $3.3 million in Q1 2026 and bottomed at $25312.0 in Q2 2024.
- The 5-year median for Shares Outstanding (Diluted Average) is $549737.0 (2025), against an average of $918995.9.
- The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) plunged 98.48%; it then jumped 5152.81% in 2026.
- Tracing FEED's Shares Outstanding (Diluted Average) over 5 years: stood at $1.4 million in 2022, then tumbled by 88.79% to $159105.0 in 2023, then sank by 83.04% to $26985.0 in 2024, then soared by 2229.2% to $628534.0 in 2025, then surged by 423.29% to $3.3 million in 2026.
- Per Business Quant, the three latest FEED Shares Outstanding (Diluted Average) figures stand at $3.3 million (Q1 2026), $628534.0 (Q4 2025), and $470940.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.29 Mn |
| Dec 31, 2025 | 628,534.00 |
| Sep 30, 2025 | 858,434.00 |
| Jun 30, 2025 | 484,566.00 |
| Mar 31, 2025 | 626,150.00 |
| Dec 31, 2024 | 26,985.00 |
| Sep 30, 2024 | 271,284.00 |
| Jun 30, 2024 | 24,074.00 |
| Mar 31, 2024 | 246,980.00 |
| Dec 31, 2023 | 159,105.00 |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2015 | 281,543.00 |
| Mar 31, 2014 | 155,009.00 |